Michael Shi
Company: Transcenta
Job title: Chief Medical Officer
Seminars:
Clinical Update on TST005 11:00 am
Updates on the current clinical trials for this bi-functional anti-PD-L1 and TGF-β trap fusion protein Exploring the findings and improved therapeutic window Future directions to ensure continued successRead more
day: Track B - Day 1 AM